Eloxx Pharmaceuticals, Inc. Business Finance Contracts & Agreements
92 Contracts & Agreements
- Assignment Agreements (1 contract)
- Debenture Agreements (2)
- Equity Distribution Agreements (1)
- Exchange Agreements (6)
- Loan Agreements (5)
- Note Agreements (5)
- Purchase Agreements (6)
- Registration Rights Agreements (5)
- Release Agreements (3)
- Security Agreements (2)
- Share Agreements (2)
- Stock Agreements (13)
- Subscription Agreements (1)
- Underwriting Agreements (4)
- Waiver Agreements (1)
- Warrant Agreements (35)
- Form of Amendment to Stock Option Agreement, dated October 16, 2024 (Filed With SEC on October 17, 2024)
- THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on November 13, 2023)
- SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on November 13, 2023)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 13, 2023)
- SCHEDULE OF WARRANT HOLDERS (Filed With SEC on November 13, 2023)
- COMMON STOCK PURCHASE WARRANT Eloxx Pharmaceuticals, Inc. (Filed With SEC on November 13, 2023)
- PRE-FUNDED COMMON STOCK PURCHASE WARRANT Eloxx Pharmaceuticals, Inc. (Filed With SEC on November 13, 2023)
- First Amendment, dated March 7, 2023, to the Loan and Security Agreement, dated as of September 30, 2021, by and among Hercules Capital, Inc., the Company, Zikani Therapeutics,... (Filed With SEC on May 12, 2023)
- Loan and Security Agreement, dated as of September 30, 2021, by and among Hercules Capital, Inc., the Company, Zikani Therapeutics, Inc. and the other parties thereto (Filed With SEC on November 8, 2021)
- Agreement and General Release, dated as of July 2, 2021, by and between Neil S. Belloff and Eloxx Pharmaceuticals, Inc (Filed With SEC on July 6, 2021)
- Underwriting Agreement, dated May 13, 2021, by and between Eloxx Pharmaceuticals, Inc. and B. Riley Securities, Inc (Filed With SEC on May 18, 2021)
- Underwriting Agreement by and among Eloxx Pharmaceuticals, Inc., Citigroup Global Markets Inc. and Piper Jaffray & Co., dated June 20, 2019 (Filed With SEC on June 21, 2019)
- Underwriting Agreement by and among Eloxx Pharmaceuticals, Inc., Citigroup Global Markets Inc. and Piper Jaffray & Co., dated June 20, 2019 (Filed With SEC on June 20, 2019)
- Loan and Security Agreement, dated as of January 30, 2019, by and among Silicon Valley Bank, WestRiver Innovation Lending Fund VIII, L.P., Eloxx Pharmaceuticals, Inc., and Eloxx... (Filed With SEC on March 14, 2019)
- Equity Distribution Agreement, dated November 16, 2018, by and between Eloxx Pharmaceuticals, Inc., Citigroup Global Markets Inc. and Cantor Fitzgerald & Co (Filed With SEC on November 16, 2018)
- Form of Restricted Stock Unit Grant Notice for Israeli employees (Filed With SEC on August 10, 2018)
- Underwriting Agreement by and among Eloxx Pharmaceuticals, Inc., Citigroup Global Markets Inc. and Piper Jaffray & Co., dated April 25, 2018 (Filed With SEC on April 26, 2018)
- Stock Option Grant Notice and Stock Option Agreement (Inducement Grant) between Eloxx Pharmaceuticals, Inc. and Robert E. Ward, dated March 5, 2018 (Filed With SEC on March 16, 2018)
- Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement (Inducement Grant) between Eloxx Pharmaceuticals, Inc. and Robert E. Ward, dated March 5, 2018 (Filed With SEC on March 16, 2018)
- Forms of Option Agreement, Stock Option Grant Notice and Notice of Exercise under the Eloxx Pharmaceuticals Share Ownership and Option Plan (2013) (Filed With SEC on March 16, 2018)
- Eloxx Pharmaceuticals Share Ownership and Option Plan (2013) (Filed With SEC on March 16, 2018)
- Specimen of Common Stock Certificate (Filed With SEC on March 16, 2018)
- CONVERTIBLE PROMISSORY NOTE (Filed With SEC on May 22, 2017)
- PREFERRED STOCK EXCHANGE AGREEMENT (Filed With SEC on February 22, 2017)
- CONSENTAND WAIVER AGREEMENT (Filed With SEC on February 22, 2017)
- AMENDED ANDRESTATED CONVERTIBLEPROMISSORY NOTE (Filed With SEC on February 22, 2017)
- CONVERTIBLEPROMISSORY NOTE (Filed With SEC on February 22, 2017)
- SEVION THERAPEUTICS, INC. PROMISSORY NOTE (Filed With SEC on November 14, 2016)
- SEVION THERAPEUTICS, INC. AMENDMENT NO. 1 TO SUBSCRIPTION AGREEMENT (Filed With SEC on October 9, 2015)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on October 9, 2015)
- Nondisclosure,Noncompetition and Invention Assignment Agreement (Filed With SEC on October 9, 2015)
- FORM OF COMMON STOCK PURCHASE WARRANT SEVION THERAPEUTICS, INC. (Filed With SEC on October 9, 2015)
- ConfidentialTreatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentialityrequest. Omissions are... (Filed With SEC on February 17, 2015)
- ConfidentialTreatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentialityrequest. Omissions are... (Filed With SEC on September 29, 2014)
- SERIES FA WARRANT AMENDMENT AGREEMENT (Filed With SEC on June 16, 2014)
- SERIES A WARRANT AMENDMENT AGREEMENT (Filed With SEC on June 16, 2014)
- SERIES FE COMMON STOCK PURCHASE WARRANT SenescoTechnologies, Inc. (Filed With SEC on May 19, 2014)
- THIS WARRANTAND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISE ARESUBJECT TO THE RESTRICTIONS ON TRANSFERSET FORTH IN SECTION 4 OF THIS WARRANT (Filed With SEC on May 19, 2014)
- SERIES FC COMMON STOCK PURCHASE WARRANT SenescoTechnologies, Inc. (Filed With SEC on May 19, 2014)
- SERIES FB COMMON STOCK PURCHASE WARRANT SenescoTechnologies, Inc. (Filed With SEC on May 19, 2014)
